Portfolio Update

RNS Number : 0417A

Intl. Biotechnology Trust PLC

13 February 2014

 



International Biotechnology Trust plc

The Board of International Biotechnology Trust plc (the "Company") notes that agreement has been reached to sell the assets of Affinium Pharmaceuticals, an unquoted portfolio company, to Debiopharm Group.

The Directors have changed the valuation of the Company's interest in this unquoted company from £0.8m to £1.8m on a cost of £0.8m to reflect this deal.  This change in valuation will be included in the Company's Net Asset Value ("NAV") at close of business today and will be included within the NAV released to the market tomorrow.  The increase in NAV per share in comparison to that released today is 1.76 pence per share.

Rhona Gregg

For and on behalf of

BNP Paribas Secretarial Services Limited

Company Secretary

Telephone:  [phone]

13 FEBRUARY 2014

 

END

 

 

PFUBSGDDCGBBGSX